BMS licenses ADC technology from Lonza

Endpoints NewsEnGene's shares crash on updated pivotal bladder cancer data

Endpoints NewsAre health insurers out of the woods after a tough 2025?

Endpoints NewsBlackstone puts $250M into Anagram to tackle cystic fibrosis complication

FierceBiotechAntibodies that stop measles from stabbing cells could become new treatments for the surging virus, study suggests

FierceBiotechBeOne shelves 5 cancer programs, halts phase 2 rheumatoid arthritis trial

Lonza NewsBMS licenses ADC technology from Lonza - The Pharma Letter

BioPharma DiveAngelini to buy Catalyst in $4B play for rare neuro drugs

BioPharma DiveEntrada shares dive as Duchenne results disappoint

Endpoints NewsEntrada stock falls on Duchenne data; Wegovy expands access

CellVirological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia

CellAffinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections

CellMulti-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome